The Therapeutic Role of Vasopressin on Improving Lactate Clearance During and After Vasogenic Shock: Microcirculation, Is It The Black Box?
- PMID: 26853286
The Therapeutic Role of Vasopressin on Improving Lactate Clearance During and After Vasogenic Shock: Microcirculation, Is It The Black Box?
Abstract
Arginine vasopressin as a supplementary vasopressor in septic shock restores vascular tone and mean arterial pressure, meanwhile decreases dose and exposure time to catecholamines. The objective of this study was to evaluate the effect of vasopressin on lactate and lactate clearance as markers of tissue perfusion during septic shock. In this prospective, randomized, controlled trial, 30 patients with septic shock were enrolled in two groups. One group received norepinephrine infusion (titrated to reach the target MAP of ≥65 mm Hg) and the other group in addition to norepinephrine, received vasopressin at a constant rate of 0.03 u/min. Serum lactate levels were assessed at baseline, 24 and 48 hours after randomization. Lactate clearance was estimated for each patient at 24 and 48 hours. Venous lactate was measured in both groups. Despite a tendency toward higher venous lactate at 24 and 48 hours in the norepinephrine group (3.1 vs. 2.5, P=0.67 and 1.7 vs. 1.1, P=0.47), the conflict was not statistically significant among them. While lactate clearance after 24 hours was significantly higher in vasopressin treatment group (46% vs. 20%, respectively; P=0.048), the 48-hour lactate clearance did not differ from statistic viewpoints despite their clinical values (66% vs. 40%, P=0.17). Although lactate levels did not significantly differ between treatment groups, lactate clearance at 24 hours was significantly higher in vasopressin group. This may be the effect of vasopressin effect on microcirculation and tissue hypoperfusion or its catecholamine sparing effect.
Keywords: Lactate clearance; Septic shock; Vasopressin.
Similar articles
-
Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.Pharmacotherapy. 2004 Aug;24(8):1002-12. doi: 10.1592/phco.24.11.1002.36139. Pharmacotherapy. 2004. PMID: 15338849
-
The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience.Crit Care Med. 2017 Jun;45(6):940-948. doi: 10.1097/CCM.0000000000002323. Crit Care Med. 2017. PMID: 28333757 Clinical Trial.
-
Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.Crit Care. 2009;13(4):R130. doi: 10.1186/cc7990. Epub 2009 Aug 10. Crit Care. 2009. PMID: 19664253 Free PMC article. Clinical Trial.
-
Role of vasopressin in the management of septic shock.Intensive Care Med. 2004 Jul;30(7):1276-91. doi: 10.1007/s00134-004-2283-8. Epub 2004 Apr 21. Intensive Care Med. 2004. PMID: 15103461 Review.
-
Bench-to-bedside review: Vasopressin in the management of septic shock.Crit Care. 2011 Aug 11;15(4):226. doi: 10.1186/cc8224. Crit Care. 2011. PMID: 21892977 Free PMC article. Review.
Cited by
-
Vasopressor-Sparing Strategies in Patients with Shock: A Scoping-Review and an Evidence-Based Strategy Proposition.J Clin Med. 2021 Jul 18;10(14):3164. doi: 10.3390/jcm10143164. J Clin Med. 2021. PMID: 34300330 Free PMC article.
-
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024.Acute Med Surg. 2025 Feb 24;12(1):e70037. doi: 10.1002/ams2.70037. eCollection 2025 Jan-Dec. Acute Med Surg. 2025. PMID: 39996161 Free PMC article.
-
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024.J Intensive Care. 2025 Mar 14;13(1):15. doi: 10.1186/s40560-025-00776-0. J Intensive Care. 2025. PMID: 40087807 Free PMC article.
-
Early management of adult sepsis and septic shock: Korean clinical practice guidelines.Acute Crit Care. 2024 Nov;39(4):445-472. doi: 10.4266/acc.2024.00920. Epub 2024 Nov 18. Acute Crit Care. 2024. PMID: 39622601 Free PMC article.
-
Clinical Efficiency of Vasopressin or Its Analogs in Comparison With Catecholamines Alone on Patients With Septic Shock: A Systematic Review and Meta-Analysis.Front Pharmacol. 2020 May 6;11:563. doi: 10.3389/fphar.2020.00563. eCollection 2020. Front Pharmacol. 2020. PMID: 32435192 Free PMC article.